In vitro assessment of drug sensitivity in acute nonlymphocytic leukemia.
D000208:Acute Disease; D000903:Antibiotics, Antineoplastic / Q000633:toxicity; D000970:Antineoplastic Agents / Q000633:toxicity*; D001692:Biological Transport; D003114:Colony-Forming Units Assay; D003561:Cytarabine / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology*; D009279:Naphthacenes / Q000633:toxicity; D011379:Prognosis; D014410:Tumor Stem Cell Assay
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009279:Naphthacenes; D003561:Cytarabine